RevPropeller Unveils New Financial Education Platform for Pastors 
Focus Graphite Announces $3.5 Million Bought Deal LIFE Offering of Units 
Ciscom Reports Q3 2025 Earnings – Positive Operating Cash-Flows 
IC Group’s Insured Creativity Division Acquires Assets of Players Health Cover Canada to Expand Insurance Offerings in Live Sports 
Turnium Technology Group Annual General Meeting Update Network Marketing Strategist Alfredo Pino is the Subject of a New Online Interview
TAMPA BAY, FL / ACCESSWIRE / September 15, 2021 / Prominent Network Strategist, Alfredo Pino,…
How Is Wanda.Exchange Transforming The Global Money Market-A Deeper Crackdown
CHONBURI, THAILAND / ACCESSWIRE / September 15, 2021 / Currently emerging as the largest Crypto…
Margaret Lake Diamonds Announces Arctic Star’s Second Round of Caustic Fusion Diamond Results Strengthens Previous Results, Sequoia Kimberlite Complex
VANCOUVER, BC / ACCESSWIRE / September 15, 2021 / Margaret Lake Diamonds Inc. (“MLD” or…
Falcon Awaits Final Approval – Warrant Exercise Incentive
VANCOUVER, BC / ACCESSWIRE / September 15, 2021 / FALCON GOLD CORP. (TSXV:FG)(GR:3FA)(OTCQB:FGLDF); (“Falcon” or…
A New Piece on Artists in the Pandemic by Joanna Cunningham
Executive Director of the Watergate Theatre in Kilkenny, Ireland has written a thought-provoking piece which…
Emily Sakamoto Launches New Blog
The Clinical Psychologist and Mercer University graduate student debuts an online journal from which she…
Cyren Announces $10.2 Million Private Placement Priced at a Premium to Market
MCLEAN, VA / ACCESSWIRE / September 15, 2021 / Cyren (NASDAQ:CYRN), today announced that it…
75% of consumers stop purchasing from a retailer due to delivery miscommunications
Research reveals UK delivery customer experience epidemic, with retailers losing customers due to poor post-purchase…
RightIndem deploys enterprise-grade conversational AI to simplify customer claims process
By partnering with Amdaris software developers, RightIndem augmented its existing software expertise and enhanced its…
Netacea engages with University of Nottingham and government funded scheme to advance threat detection and mitigation offering
Netacea reveals how the partnership contributed to evolving its product suite and helped cut onboarding…
Opera GX integrates CORSAIR iCUE to give a splash of color to gamers’ browsing
OSLO, Norway, Sept. 16, 2021 /PRNewswire/ — Opera GX is introducing iCUE integration that makes CORSAIR…
Launch of Oxitope Pharma, a biopharmaceutical start-up dedicated to the discovery and development of antibody-based medicines for the treatment of diseases caused by oxidative stress
PRESS RELEASE Launch of Oxitope Pharma, a biopharmaceutical start-up dedicated to the discovery and development…
MacroGenics Announces Preliminary Clinical Results from Phase 1 Cohort Expansion of the Ongoing MGC018 Study Presented at ESMO 2021 Virtual Annual Congress
Metastatic castration-resistant prostate cancer (mCRPC): 21 of 39 patients (54%) achieved ≥ 50% prostate-specific antigen…
MacroGenics Announces Clinical Results from Cohort A Part 1 of Phase 2/3 MAHOGANY Study of Margetuximab in Combination with Retifanlimab in Gastroesophageal Adenocarcinoma at ESMO 2021
21 of 40 patients (53%) achieved confirmed responses by independent review, exceeding prespecified futility boundary…
Athenex Presents Data from Oral Paclitaxel + Pembrolizumab Phase 1 Study at ESMO 2021
Safety Data Help Establish Part B Dose Expansion and Phase 2 Dose; Data showed encouraging…
Acepodia Presents Positive Interim Phase 1 Feasibility Data for Antibody Cell Effector Therapy, ACE1702, in Advanced HER2-Positive Tumors
Interim results from ongoing Phase 1 dose-escalation study demonstrate safety and tolerability of repeat dosing…
Acacia Pharma Announces Initiation of Pivotal Study of Byfavo® in Pediatric Procedural Sedation
This announcement contains inside information for the purposes of Article 7 of the Market Abuse…
NICE Recommends BioCryst’s ORLADEYO® (berotralstat), the First Oral, Once-daily Therapy, to Prevent Attacks in HAE Patients in the UK
RESEARCH TRIANGLE PARK, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Mountain Valley MD Holdings Announces Voluntary Retraction of a Reported Data Set, No Material Change to Business Plan Anticipated
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in Aggressive Forms of Prostate Cancer at ESMO
BXCL701 plus KEYTRUDA® (pembrolizumab) demonstrates encouraging anti-tumor activity in heavily pre-treated mCRPC patients with adenocarcinoma…